Latest News and Press Releases

PITTSBURGH, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Motivation Champs Media, a publishing company committed to encouraging authors and sharing inspiration, announces the publication of The Waterloo...

Z-pods significantly improved outcomes in mouse model of cutaneous lupus GREENVILLE, SC, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The Z-pod® topical delivery platform was used in various in vivo...

The authors conclude that “nasal anti-CD3 has the potential to be a non-toxic novel immunotherapeutic approach for the treatment of Alzheimer’s disease (AD)”FDA has cleared the IND for intranasal...

Pittsburgh, PA, Dec. 28, 2022 (GLOBE NEWSWIRE) -- We are excited to announce that Ganesh Ranganathan, Chairman, and CEO of Integra Global Solutions’ article has been published in the Voices segment...

SAN DIEGO, July 12, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company, announced today their...

Venice, FL USA, June 01, 2022 (GLOBE NEWSWIRE) -- LiveCare Inc. OTC:(LVCE), With the completion of its fiscal year 2021 PCAOB audit, validates its proof of concept as an innovative leader in the...

Carlsbad, CA, May 25, 2022 (GLOBE NEWSWIRE) -- In the midst of Skin Cancer Awareness Month, Colorescience®, a leading dermatologist-recommended specialty skincare and cosmetics company announces...

PHILADELPHIA, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), reported today a new peer reviewed publication entitled, "The Quest for...

PHILADELPHIA, Aug. 4, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced today a peer-reviewed electronic publication entitled "Sensitivity of SARS/MERS CoV to Interferons and...

PHILADELPHIA, April 8, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE:HEB) (the "Company" or "Hemispherx") announced today the peer-reviewed publication titled "Discordant Biological and...